4//SEC Filing
Genextra S.p.A. 4
Accession 0001559515-20-000001
CIK 0001270073other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:46 PM ET
Size
4.9 KB
Accession
0001559515-20-000001
Insider Transaction Report
Form 4
Genextra S.p.A.
10% Owner
Transactions
- Sale
Common stock, par value $0.001 per share
2020-05-13$84.60/sh−595,578$50,385,899→ 5,500,000 total
Footnotes (1)
- [F1]Genextra S.p.A. will apply the proceeds from the sale to reduce outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
IncorporatedItaly
Related Parties
1- filerCIK 0001559515
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:46 PM ET
- Size
- 4.9 KB